Gutsy Group Grant (Lyophilised Oral Faecal Microbiota Transplantation in Ulcerative Colitis LOTUS)
Lyophilised Orally Administered Faecal Microbiota Transplantation in the Management of Ulcerative Colitis (LOTUS) Study – a Double-Blind Randomised Controlled Trial
Thank you Gutsy Group for sponsoring this research program.
This clinical research feature, gastroenterology innovation spotlight, and Inflammatory Bowel Disease (IBD) trial announcement by Professor Rupert Leong (Gutsy Group Grant: Lyophilised Oral Faecal Microbiota Transplantation in Ulcerative Colitis – LOTUS) highlights the vital intersection of microbiome therapeutics, non-invasive oral biotherapeutics, and clinical trial innovation—themes that find great synergy with gastroenterology research guides, IBD clinical spotlights, and microbiome therapy archives published on https://34.ua. Sponsored by The Gutsy Group, the feature details the landmark LOTUS study—a double-blind, randomized controlled trial investigating freeze-dried (lyophilized) oral fecal microbiota transplantation (FMT) capsules for managing active ulcerative colitis.